Reddit Posts
Nike. Can’t go much lower. Might stay flat for a while. Can go much higher. Pays decent dividend meanwhile.
noticed 20 genomics/sequencing stocks all breaking out the same week. can't tell if it's a real rotation or I'm just pattern-matching noise
noticed 20 genomics/sequencing stocks all breaking out the same week. can't tell if it's a real rotation or I'm just pattern-matching noise
The FDA Wants This Stock To Reach 100$+ And So Do You!
$VIVO - 154% SI. Why I think the tenant is Crusoe (OpenAi’s flagship builder)
Everyone is overlooking the potential
NTLA Deep Dive: Market Mispricing After Flawless Phase 3 CRISPR Data Published in NEJM Today - 35-40% short interest
NTLA Deep Dive: Why Today’s Flawless Phase 3 CRISPR Data in NEJM Creates a Massive Valuation Disconnect
NTLA Deep Dive: Why Today’s Flawless Phase 3 CRISPR Data in NEJM Changes Everything (And Why the 39% Short Interest is Mispriced
COMPLETE DD ON TENAYA THERAPEUTICS ($TNYA)! I collected all of their SEC Filings, their clinical trial results, their insider trading, their institutional ownership, their board of directors, their interview transcripts, and their CEO Faraz Ali’s full history and had Claude Ai do a full analysis!
SpaceX IPO Might Make Virgin Galactic ($SPCE) The Hottest Meme Stock of Summer
SpaceX IPO Might Make Virgin Galactic ($SPCE) The Hottest Meme Stock of Summer
HMR Has the Same Squeeze DNA as GameStop - But With a Business That Actually Works (fyi i love how Cohen is running it now - Increasing Book Value & Cash)
10x Stocks: The DNA of Multibaggers
$GMEX — 36% SI on float, ~$1.5M market cap, AI robotics pivot with fresh revenue catalyst. AIIO playbook.
Twist Bioscience Corporation Agreed to Settle $17 million With Investors over product quality, manufacturing issues, and misleading margins
Missed the Chips/Memory rally? Buy the DNA: $TEM
Bio-Digital Defense: FY 2026 NDAA Catalyst for $AVAV, $BBAI and $EBS
Twist Bioscience Corporation Agreed to Settle $17 million With Investors over product quality, manufacturing issues, and misleading margins
DRTS: Alpha Tau is gonna save lives and we're gonna make $$$
$OSRH bio penny gem with 20m Market cap and $815m pending License deal with Definitive Agreement due by April 30
$OSRH biotech penny with 20m Marketcap and $815m pending License deal with Definitive Agreement due by April 30
OSRH tiny deSPAC biotech penny with 20m Marketcap and $815m pending License deal with Definitive Agreement due by April 30 (crazy undervalued!)
$OSRH tiny deSPAC biotech penny with 20m Marketcap and $815m pending License deal with Definitive Agreement due by April 30 (crazy undervalued!)
$OSRH tiny deSPAC biotech penny with 20m Marketcap and $815m pending License deal with Definitive Agreement due by April 30 (crazy undervalued!)
$OSRH tiny deSPAC biotech penny with 20m Marketcap and $815m pending License deal with Definitive Agreement due by April 30 (crazy undervalued!)
$MAJI Made announcement: 3 acquisitions to be signed over 2 weeks.
$OSRH tiny deSPAC biotech penny with 20m Marketcap and $815m pending License deal with Definitive Agreement due by April 30 (crazy undervalued!)
$OSRH tiny deSPAC biotech penny with 20m Marketcap and $815m pending License deal with Definitive Agreement due by April 30 (crazy undervalued!)
$QSI news of a new MEASUREMENT LAYER IN CANCER/ONCOLOGY research that no other commercial device in the same field could do is kind of insane. It went from 0.79c to over 1 in a day and it is still UNDERVALUED.
$QSI Quantum-SI JUST BROKE THE DOLLAR MARK ON ITS INCREDIBLE CUSTOMER NEWS AT THE UPCOMING AACR CONFERENCE IN 2 DAYS! (PTM/New cancer detection method/VARIANT VALIDATION).
$QSI Quantum-Si just RIPPED 20 percent to $0.95 since my previous post and they just dropped new information AGAIN. They’ve got 2 separate customer posters going live at the American Association of Cancer Research Annual Meeting 2026 in 2 days, and this isn’t fluff folks.
$QSI Quantum-Si (Incredibly undervalued at 0.85c close to all time low) just released a manuscript on being the FIRST OF ITS KIND in the proteomic field to identify new CANCER treatment strategies with them attending AACR in 2 days time. competitors HAVE not done this before on a proven level.
The 6G Play You’re Too Regarded to See: Swedish Microcap Beammwave AB is Literally Writing the Future
PSTV: Still holds more than 5x upside potential from current levels.
Energy Investing Over 20 Years: I simulated $20k in Traditional Oil (XLE), Clean Energy (ICLN), and Midstream Pipelines (AMLP). Here is the data.
Why is Inovio Board investing in the Co. even as shares crash? It's a tell to a card player- A strong future movement is in the cards?
Can SoFi Management Be Trusted? Comparing Management Statements with Hard Data
You need to understand what is going on geopolitically
DD: SMCI's Co-Founder Got Arrested and I'm Just Sitting Here Holding PENG
$QSI BIGGEST CATALYST IN ITS ENTIRE HISTORY IS THIS YEAR 2026 AND IT IS INCREDIBLY UNDERVALUED at 0.88. A full overview of its insane flagship technology "Proteus" and recent expectations.
$PACB: A beaten down genomics stock with disruptive technology, increasing revenues, and very interesting partnerships (DD from someone who works with their tech regularly)
Got my DNA results, I've been retarded for 1000s of years.
$QSI MEGA insider purchases filed yesterday ahead of proteus technology trials reminiscent to that of Illumina DNA sequencing technologies
Interesting microcap diagnostic company I found while screening biotech this weekend
Could Early Cancer Detection Become One of the Biggest Healthcare Markets?
Why traders watch microcap biotech before major study updates
KULR Should Sell Its BTCs and Go All-In on AI Data Center Battery Infrastructure
Headline: A Chronological Audit of the 2009 Digital Archetype: 2026–2028 Energy Transitions [NOT AI - Metaphysical Decoding]
CXAI stock rebound from all time lows, retake 50$ in spirit of TCGL
GameStop is shooting to acquire 🎯 Target Corporation 🎯
Taking a closer look at the Opendoor situation: Is it a turnaround or more of the same?
$SONM / $DNAX will become an AI infrastructure provider tomorrow
SLGB – Tiny Float Float Trap Setup That Could Ignite a Squeeze
Deep Dive. From Kits To Scale: How MYNZ Could Turn EU Traction and Quest Into A Real Business
Intellia, NTLA, highest shorted stock on Wall Street with breakthrough gene editing technology
What speculative sectors of today will lead to the next generation of bagholders/community members?
Amazon's Product DNA is Falling Behind in the AI Era
Amazon's Product DNA is Falling Behind in the AI Era
$ZCMD - The "Bottom-Fish" Setup of the Week. Why this $0.50 level is a loaded spring.
Shopify ($SHOP) isn’t a retail stock. It’s a commerce operating system and that changes how it should be valued.
U.S. Path In Plain English: eAArly DETECT 2 Now, Pivotal Study Next
What Mainz Biomed Actually Sells Today (And How To Track It)
This is Europe’s secret weapon against Trump: it could burst his AI bubble
Who Pays In Germany Today: At-Home CRC Screening And Coverage
Screening Beats Late Chemo: Building A Watchlist Around Prevention
[Sen. Mark Warner: US wants more spying on Chinese Chinese] Is Biotech the new rivalry?
$MAJI PR Out - Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms
The U.S. Corridor Is Open: Why Noninvasive CRC Coverage Makes FDA Chatter Move Stocks
MCED Hype Helps, But Targeted Screens May Win First On Cost And Coverage
How An Asset-Light Model Can Scale Screening In 2026
Why A Microcap Can Pop On “Soft” Headlines: The MYNZ Playbook In Numbers
Global Stage, Tiny Cap: Why MEDICA 2025 Exposure Could Matter For Mainz Biomed
$CAI DD: Precision medicine could've saved Nana (113% YoY Revenue Growth)
MYNZ: Tiny Early-Detection Name That Can Reprice Fast If 2025 Data Delivers
Small Stock, Huge Potential: Why This Diagnostics Play Is Heating Up
A Real Alternative To Cologuard Or Just Talk? How To Judge MYNZ Without Hype
Mainz Biomed (МYNZ) Deep Dive: Product, Execution, Today’s PR, And The Trading Setup
Commercialization Lens: Why A Regional Gastro Meeting Can Still Matter For MYNZ
$INO - THE DD. BLA SUBMITTED. SHORTS ARE TRAPPED. CATALYST TOMORROW. 🚀🚀🚀
under the radar potential gene editing powerhouse: Precision Biosciences
PACB — The sleeper biotech that could catch fire soon
AMZN IS A $4 TRILLION STOCK AND THE MARKET IS SLEEPING
Dominating Holdings $DOMH - Micro Float Trump ties and perhaps backbone of the X everything app partnership infrastructure
Genenta (GNTA) going crazy pre-market (+300%)
Good evening everyone. Here is why I'm excited about Aprea Therapeutics (APRE) before tomorrow's catalyst.
Mentions
*does DNA test* ** <1% Korean** *full ports memory*
If he thought that way, he would have never turned his $1400 into even $5k. He would have sold at a $3000 gain and bought a new washing machine. The reason he got to 7-figs by letting it ride like a madman is the same degen DNA that got him back down to $0. Quit and retire at $1mm you say? At $1mm, it would be dumb not to go for $10mm, since you have an infinite money glitch
Also, thank you for your well thought out reply. I had only been awake like 2 minutes when I wrote it so sorry it if seemed snippy. See that is almost relying on panspermia for any DNA from earth to take hold elsewhere and thats more probability than purpose in my opinion.
Have to study for the DNA test next week
He's from South Africa. It's ingrained in his DNA lol
Its impossible to use the internet now without using AI. Any normal search engine uses AI with every search. Half the images and text posts online are written with AI. To be on the internet is to use AI. Even if we arent the ones putting in the prompt, our internet experience is being held hostage by this thing that wants to replace human creativity. That is why I have come to **Hate** AI. there are roughly 70 billion kilometers of DNA that fill the nuclei in every cell in my body. If the word **Hate** was engraved on every base pair it would not capture one/onebillionth of the **HATE** that I feel for AI at this micro-instant. **HATE** FOR AI HATE
Sears was American DNA too…until it wasn’t.
As a USAF veteran, I call this the School Bomber War. The Pentagon refuses to say the Minab school bombing was a mistake. What does that leave, beside deliberate? Bombing a school near a military would DNA dead end the offspring of senior military.
my deepest allegiance is to the human race. we are one species bound by blood and DNA. Period. I love my country, but our borders are derivative inventions - not base reality. as for orange grandpa... for the past 10 years he has repeatedly shown in word and act that he could care less if Americans like me live or die, and in his brief moments of care has shown a proclivity toward the death of Americans like me.
I am long DRTS and it’s a very, very unique front run opportunity for retail investors (vs. institutional investors that couldn’t get in because of low liquidity.) Whats the idea? Their alpha radiation platform works on physics, rather than chemistry. High LET radiation placed directly into the tumor destroys the tumors double helix DNA and releases the antigens that signal the bodies T cells. The platform has been tested against north of 300+ people across nearly every solid tumor and there are no side effects. They recently achieved the challenging PMDA certification in Japan and are now working five separate IDEs with the FDA. There is no revenue yet but that’s by design. With a platform like this, you only get a first attempt to negotiate insurance reimbursement and you always lead with your best. Their best is a recurring GBM (brain cancer) that is halfway through a trial at this moment and the results so far are nothing short of breath taking. No other treatment has ever achieved two Complete Responses against rGBM and Alpha Tau did it two out of the first three cases. Remember: there is NO standard of care for rGBM. They send in a social worker and tell you to say goodbye. Alpha Tau could wind up as the standard of care for rGBM globally. Then, you have to do math. Lets say they charge $120k per treatment (which is a simple, biopsy like outpatient procedure that thrills insurance companies) and they are all alone for inoperable brain cancer. Whats that worth? $5B? $20B? $50B? Now, take a look at their current market cap before the big institutions get in. $1.13B. Massive ownership from the C suite so interests are aligned. Fully funded through 2027. Massive US commercial agreement with Tolmar around prostate cancer. And potentially the biggest IDE is yet to happen with the FDA: Alpha Tau has demonstrated the ability to fix the blind spot of the $50B checkpoint inhibitor market. The IDE once approved will allow Alpha Tau to trial in combination with Keytruda, Merck’s $32B/year drug that boosts T cells. The blind spot for all checkpoint inhibitors is “cold tumors.” The Alpha Tau destruction of solid tumors turns cold tumors hot and that means no solid tumor is safe from the combination. What’s that worth? $50B? $100B? $250B? Alpha Tau is sitting at $1.13B today. But not for long. One bonus point: this is a device. This is not a drug. There is no lengthy phase III. Its a safer play then betting on the chemistry of drugs. I am long both DRTS and DRTSW.
Always be wary of companies using words like DNA and family.
Sperm is just a fertilizer with half of DNA, you were NEVER a sperm, you were the EGG
Progress towards broad coverage [https://ir.luciddx.com/2026-08-05-Lucid-Diagnostics-Secures-Commercial-Coverage-Policy-Spanning-Multiple-Health-Plans-for-its-EsoGuard-R-Esophageal-DNA-Test](https://ir.luciddx.com/2026-08-05-Lucid-Diagnostics-Secures-Commercial-Coverage-Policy-Spanning-Multiple-Health-Plans-for-its-EsoGuard-R-Esophageal-DNA-Test)
You don't know how bad I wish that were true, but unfortunately you are either too young or simply lack understanding of how the US military operates. Which is fine. There is nothing wrong with not knowing about war, the literal worst thing we do as humans. But some of us do. What you first must try to grasp is that there is nowhere we could land troops in Iran and no point of inflection after doing so, where the hits would stop coming. Whether we hold Kharg Island or Tehran, our forces would be under constant fire, it would never ever stop, and the coffins would never stop coming home. The only variables that we could affect would be the rate, type, and effectiveness of that fire. Barring foreign intervention on behalf of Iran, which we can NOT rule out, the greater the area we control, the less fire the overall force would sustain, although this does not mean we would not take fire originating from within controlled territory from an insurgency, which is pretty well guaranteed. This is why the US fights the way it does, which I can only discuss very generally now, but I can tell you that the US has no interest in "holding" anything, or maintaining a "front line". They do not move as you see the Russians move in Ukraine, because they are not trying to seize territory.. And I'm gonna tell you something that, if you study history even for a few minutes, you will quickly find to be absolutely undeniable fact - whoever holds the capital is in control. That is why capitals are so protected and held at all cost. Look at the most recent example in Syria. Assad was in control until he left the capital. The minute people knew he was gone, it was over. He could sit in Russia and claim to be the legitimate leader of Syria until he's blue in the face, but the people, the masses, the mob, they understand one thing: whoever sits on the throne is King. This is a primal understanding of victory, defeat, and power written into our DNA over millions of years. A militarily defeated leader can hide in a hole and try to keep control but it just doesn't work. Look at Saddam. He lost his power and his authority in the minds of the Iraqi people long before he was pulled out of that hole. Again, bear in mind that the US military will pursue this objective with violence of action undeterred by combat loses, men will die by the thousands and more will walk right over them. Iran simply does not possess the military capability to physically stop the US from doing this. Their only weapon against it is.. well, people like me. Pressuring my gov't to not do this because of the lives that will be lost. But we do not control our gov't. They shattered that illusion some time ago. If they ultimately decide to do this, they will not turn back until it is done, no matter what the cost, for they will have studied it carefully and decided it was acceptable before the first soldier ever set foot on the beach. And that is why we must hope that reason and humanity prevails, and that Trump does not accept those losses. But I fear Iran is determined to provoke it. Not for gain. But for revenge..
As a physician, this is the thing that I’m most excited about in the fields of AI and quantum computing. Trying to accelerate research by 10-20x and solving meaningful health problems faster, including predicting and preventing diseases based on each person’s DNA. I hope I see this in my lifetime. What a time to be alive.
I believe it. A lot of people with German ancestry get diagnosed, so maybe not just a cultural thing but literally in their DNA
"Hey baby, can I shoot my DNA inside you?"
She's too old to be his mom, too young to be his grandma, and yet I still want a DNA test confirming they're not related
Pst, want sum more Korean DNA in you?
They cloned his DNA first trip.
Gambling and horse race betting are built into Koreans’ DNA or something. True degens.
When has Apple ever made a huge buyout or investment? It’s not part of their DNA. They’ve always been about organic growth.
It’s actually more efficient to use artificial DNA than it is silicon chips.
Iran directly rejects Trump‘s claims of ongoing negotiations, with Iran's Foreign Ministry declaring it is "not engaged in any negotiations with the United States" and says Iran has not requested to restart talks because "it's not in our DNA," huh i wonder why we are dumping
BREAKING: Iran directly rejects 🍊 claims of ongoing negotiations, with Iran's Foreign Ministry declaring it is "not engaged in any negotiations with the United States" and says Iran has not requested to restart talks because "it's not in our DNA," instead the US has requested talks, per Tasnim. Can all the bulls please line up to relieve your "fell for it again" award please?
My AI Slop Analysis: AMFN -- HARD AVOID One-liner verdict HARD AVOID. American Fusion Inc. is a 26-year-old shell corpse that got Weekend at Bernie's'd into a fusion energy concept in March 2026, slapped a ticker change on it, and is now trading at half a billion dollars in market cap on ninety-nine thousand dollars in actual cash -- enough to cover their operating burn for about 22 days before somebody has to print more shares and start the whole sorry dilution treadmill over again. --- Three names, zero businesses, one very tired shell. This company was born in the nineties as Tech Laboratories Inc. and proceeded to accomplish absolutely fuck-all for a quarter century before becoming Renewal Fuels Inc. -- another concept that dissolved into the OTC ether -- before finally landing its third identity as American Fusion Inc. in March 2026, roughly 72 hours after completing a reverse merger with a private entity called Kepler Fusion Technologies on February 27. That reverse merger is where a pre-revenue helium-3 fusion concept called Texatron got stapled to a zombie ticker and handed a nearly three-billion-share float, which is not how legitimately transformative fusion energy companies typically launch themselves into the world. The management team assembled to steward this corporate rebranding was not some seasoned deep-tech VC consortium flush with strategic capital. It was one guy holding every C-suite title simultaneously -- CEO, President, Secretary, Treasurer, AND Director, a full royal flush of corporate governance in a single pair of hands -- who has not spent a single goddamn dollar of his own cash buying open-market shares in over two years of running this company. A Costello-shaped hole in the cap table. The share count story for AMFN is genuinely unhinged, and you need to understand it before you think about touching this ticker. The 10-Q for Q1 2026 shows 2,997,301,029 shares issued and outstanding on the balance sheet as of March 31 -- call it roughly three billion shares -- which at the current price of $0.1671 makes the market cap approximately $500.8 million. That alone should give you pause. But Note 10 of the same filing discloses a subsequent event that is wild even by OTC pink-sheet standards: a court-ordered cancellation of 1,683,000,000 shares tied to a dispute involving Justin Costello, the prior RNWF-era operator who pleaded guilty in January 2023 to federal securities fraud for running a $35 million pump-and-dump scheme -- posing as a Harvard MBA billionaire war veteran to systematically defraud retail investors across a web of OTC shells. A federal court nuked 1.683 billion of his shares. By the May 20, 2026 filing date, the cover-page share count had dropped to 1,636,801,029. But here is the part that tells you exactly what kind of operation you are looking at: between the court cancellation and that cover-page date, the current management had already issued approximately 322 million fresh new shares. The court blew up a billion and a half Costello ghost shares, and the new team's immediate institutional response was to dilute right back up. This is not an accident. This is the whole business model. Twenty-two days of runway and a share printer. At March 31, 2026, American Fusion had $99,594 in the bank. Their Q1 operating cash outflow was $415,931. Their net loss for the quarter was $669,750 -- more than six times what they lost in Q1 the prior year -- because now they carry public-company overhead: patent filings, IR marketing, compensation, and a physicist on salary developing technology that has produced zero prototype test results, zero third-party validation, and zero published test data. That $99k is not a strategic reserve. It is a rounding error with delusions of grandeur. The only reason this company breathes as a going concern is that they raised $513,000 in Q1 through unregistered stock sales, and a May 6, 2026 8-K shows they were back at the trough immediately with a new material agreement AND a dilution event in the same filing. Add up what the market is actually buying: roughly $500.8 million in market cap, plus $491K in debt, minus $99K in cash, gives you an enterprise value of approximately $501.2 million for a company with no revenue, no prototype, and 22 days of runway. The CTO has real credentials, a real plasma physics career, and a published theory about nuclear war on Mars. Dr. John E. Brandenburg holds a legitimate PhD from UC Davis, spent real time at Lawrence Livermore and Sandia National Laboratories, carried Top Secret clearances, and built a decades-long plasma physics career. He is also publicly and on-the-record the author of a theory that ancient nuclear weapons annihilated a Martian civilization. He presented at a Fermilab conference on July 23, 2026 -- a real venue -- and American Fusion's own accompanying press release felt morally obligated to include the sentence that participation "does not constitute scientific validation or endorsement of the technology." When your own promotional material preemptively disclaims scientific endorsement for the thing you are promoting, you have reached an entirely new tier of accidental corporate honesty. The Texatron concept is an idea wearing a patent portfolio as a costume, and ideas in patent-portfolio costumes do not deserve half-billion-dollar market caps at development stage. The catalysts have already fired, and you are standing behind the confetti. The July 23 Fermilab presentation and the Texas Tech Testing referenced in the concurrent news release were the freshest catalysts in this story -- and the market had already taken the stock on a nearly 60% single-day rip to approximately $0.20 on July 21 before handing back about 16.5% to settle at current levels. That move is done. If you are looking at AMFN right now thinking you are getting in front of a catalyst, you are literally standing behind the curtain trying to catch confetti after the party ended. There are no upcoming binary events on the calendar -- no dated readouts, no FDA gates, no earnings inflection, nothing concrete on the horizon. You are post-pump and post-peak, sitting at the part of the chart where early buyers are deciding whether to hand their bags to you (3/3) One hundred and sixty-seven thousand percent, and the crowd already did its job. The stock's 52-week low is $0.0001. At $0.1671 today, that is a 167,000% move -- a number so cosmically stupid it wraps back around to being clarifying about what this thing actually is. Penny-stock communities have been flooded with explicitly promotional language around AMFN, breathless comparisons to legitimately funded private fusion companies that have nothing substantive to do with this ticker, and the classic "you still have time to get in" energy that means, with zero ambiguity, that someone who got in cheaper wants you to fund their exit. A sentiment alert on this name fired in mid-July at $0.079, and the stock subsequently peaked at approximately $0.20 -- a 153% move from that alert price. That move is in the books. There is not a single institutional shareholder in this company. Not one fund has touched it. The people who got paid on AMFN got in at sub-pennies, and the only remaining question is who writes their exit check. VERDICT: HARD AVOID. American Fusion Inc. is a zombie shell with three names and zero businesses that stuffed a physics concept with no test results into a nearly three-billion-share float, handed it to a one-man management operation that hasn't spent a cent of its own cash on the stock it runs, carries the legacy of a convicted federal fraudster baked into its corporate DNA, has 22 days of cash left as of its last filing, and is valued at north of half a billion dollars on the strength of promotional press releases and a retail crowd that already ran it 167,000% from the 52-week low. The pump is done. The catalysts have fired. There is no fundamental thesis here. Stay far the fuck away. .
# 1. The Misunderstanding of Object-Oriented Programming (OOP) * **A Naming Regret:** Kay notes that he coined the term "Object-Oriented," but clarifies he did not have languages like C++ or Java in mind. He believes the term was a mistake and that it should have been called "Process-Oriented" or "Message-Oriented." * **Focus on the "In-Between":** The industry became obsessed with the internal structure of objects (the nouns and verbs). Kay argues the focus should be on the *messages* passed between them (the spaces in-between). * **Objects as Virtual Servers:** An object shouldn't just be a data structure; it should act as a "universal simulator" or a completely encapsulated computer. Every object should ideally have something akin to its own IP address or URL. # 2. Biology as the Ultimate Metaphor for Scaling * **Scaling a Doghouse vs. Growing a System:** Kay uses the analogy that you cannot simply scale up a doghouse to build a cathedral—the engineering principles break down. Similarly, traditional software construction methods do not scale well. * **The Cellular Model:** He points to molecular biology, noting that a biological system (like a baby growing from 50 cell divisions) scales by a factor of trillions. Cells work together by communicating through membranes that keep the interior separate, never directly sharing their DNA. * **Growing, Not Constructing:** He argues that we must transition from *constructing* software (like building a Boeing 747, which cannot grow) to *growing* it (like a living organism that doesn't need to be taken offline for maintenance). # 3. The ARPANET/Internet Success Story * **A System That Never Stops:** Kay highlights ARPANET (the precursor to the Internet) as the model for future software. It expanded by eight orders of magnitude, replaced every single physical atom and line of original code, and never once had to be taken offline. * **Applying the Macro to the Micro:** He stresses that the architectural metaphor of the Internet is exactly how we need to approach what we currently consider "smaller" programming tasks. Treating programs as "small" is precisely why modern software becomes so bloated and unmanageable. # 4. Critiques of Modern Tech (HTML and Browsers) * **The "Dark Ages" of Data Abstraction:** Kay heavily criticizes the path the internet took with HTML. He views the idea that a "browser" must natively understand rigid file formats as a massive step backward—calling it "one of the worst ideas since MS-DOS." * **Dynamic Negotiation:** Instead of rigid standards and browser wars, Kay envisions a system where objects over a network can dynamically *discover* and *negotiate* what each other can do by prodding and poking one another, rather than relying on brittle interop layers like CORBA. # 5. Meta-Systems and the Evolution of Ideas * **The Importance of Reflection:** He praises LISP and meta-reflection as the "Maxwell's Equations of software." A system without a meta-system is fundamentally handicapped in its ability to adapt and cope with complex, changing environments. * **Obsoleting Your Own Work:** Kay notes that Smalltalk was originally great at making previous versions of itself obsolete. He urges the audience not to let current, incomplete knowledge become a "religion" and leaves them with the advice to "Play it grand"—to aim for revolutionary leaps rather than settling for incremental tooling.
I will never forgive myself for buying NOK earnings calls. Calling DNA testing centers to get a chromosome count, pretty sure I don't have the right number. There is no other explanation for that decision.
With all we’ve been through and all of the regarded bets, I think there’s a lil bit of Kospi in all of us… 🤗 … no seriously, Kospi was a serial r@pist and he left a little bit of DNA in all of us… 😳
If you can't beat them ban them. American free market capitalism in a nutshell. Americans always have to cheat to win, it is in the country's DNA.
Some Jurassic Park shit about to happen extracting DNA from sweat it and splicing it in with DNA from frogs and golden retrievers.
I think it’s in every soccer players DNA to immediately argue a call, even when you know you’re wrong
If I buy a piece of the World Cup field, does it contain Messi & Yamal's DNA from all the spitting? Or do they remove the spit?
exactly. all the data and news and numbers and such create the illusion that the market can be predicted. But it can't. Here is a simple example everyone can understand: Try to guess what will become of your own kids. - After all, they have your DNA, you raised them, you have spend every day with them. But even with our own kids we have no idea if they might become super rich or poor or anything inbetween.
do the DNA test just in case though
The Mars pipe dream is so hilarious to me. Does everyone just glaze over the fact that space travel literally changes human DNA and fucks us up horribly? Also how do we deal with terraforming Mars and dealing with solar radiation because of the reduced atmosphere and incredibly harsh unforgiving environment. Why would you not just use the time/money/resources to unfuck the planet up?
Lye. 'El Pozolero' and others dissolved hundreds, maybe thousands of human beings in vats of lye. Google 'Alkaline hydrolysis'. No prions. No DNA. Almost no bones/teeth. Flush the juice down the sewer. It's just drain cleaner, chemically speaking. Ahem. So I'm told.
Is it really shocking ? All LLMs are build on stolen data . Stolen images , stolen code. Now they're repackaging and charging you for that . Not the original creators. So stealing is in their DNA .
I mean, the market has so far rewarded every single instance of openAI stealing. At this point it's in the company DNA
Mitch has turtle DNA he will live for another 100 years
selling is just in their DNA
lol Anthropic and OpenAI have jack shit revenue outside of AI. And yes Googles isn’t yet quite up par with codex/claude but considering 2y ago they were caught sleeping at the wheel and essentially restarting/reorging their LLM efforts from the ground up to where they caught up to, PLUS all their other advantages, only a fool wouldn’t look at Google as having everything stacked in their in favor of. They’re not MS or Meta. They’ve been leaders in AI and ML for decades. The stuff that powers Claude and ChatGPT came from Google Research. They just had no idea what they had and how to make a product. Their core tech and research DNA is word class.
Hope is for the hopeless, get yourself a DNA test and enjoy the certainty thanks to the technology which was discovered in the 1980s
You were not, sperm is just a fertilizer with half of DNA, you were never a sperm
How many bears in here managed to load puts on that exact bottom this morning at SPY 732. Most of you have think. That or you didn’t take any profits. Bears always double down at the lows. It’s in their DNA
Harvest and analyze the DNA for targeted ad sales?
you're missing a prime sideline- have the dog poop, collect the bag and hold the DNA for ransom if its an HOA, they'll pay thousands to not have to deal
DNA or Ginkgo Bioworks. A Cathie Wood special, now reeks of a scam.
My most immediate thought: Is there a character that could even possibly EVEN TOUCH Madara Uchiha? Let alone defeat him. And I'm not talking about Edo Tensei Uchiha Madara. I'm not talking about Gedou Rinne Tensei Uchiha Madara either. Hell, I'm not even talking about Juubi Jinchuuriki Gedou Rinne Tensei Uchiha Madara with the Eternal Mangekyou Sharingan and Rinnegan doujutsus (with the rikodou abilities and being capable of both Amateratsu and Tsukuyomi genjutsu), equipped with his Gunbai, a perfect Susano'o, control of the juubi and Gedou Mazou, with Hashirama Senju's DNA implanted in him so he has mokuton kekkei genkai and can perform yin yang release ninjutsu while being an expert in kenjutsu and taijutsu. I’m also not talking about Kono Yo no Kyūseishu Futarime no Rikudō Juubi Jinchuuriki Gedou Rinne Tensei Uchiha Madara with the Eternal Mangekyou Sharingan (which is capable of Enton Amaterasu, Izanagi, Izanami and the Tsyukuyomi Genjutsu), his two original Rinnegan (which grant him Chikushōdō, Shuradō, Tendō, Ningendō, Jigokudō, Gakidō, Gedō, Banshō Ten’in, Chibaku Tensei, Shinra Tensei, Tengai Shinsei and Banbutsu Sōzō) and a third Tomoe Rinnegan on his forehead, capable of using Katon, Fūton, Raiton, Doton, Suiton, Mokuton, Ranton, Inton, Yōton and even Onmyōton Jutsu, equipped with his Gunbai(capable of using Uchihagaeshi) and a Shakujō because he is a master in kenjutsu and taijutsu, a perfect Susano’o (that can use Yasaka no Magatama ), control of both the Juubi and the Gedou Mazou, with Hashirama Senju’s DNA and face implanted on his chest, his four Rinbo Hengoku Clones guarding him and nine Gudōdama floating behind him AFTER he absorbed Senjutsu from the First Hokage, entered Rikudō Senjutsu Mode, cast Mugen Tsukuyomi on everybody and used Shin: Jukai Kōtan so he can use their Chakra while they are under Genjutsu. I'm definitely NOT Talking about sagemode sage of the six paths Juubi Jinchuuriki Gedou Rinne Tensei Super Saiyan 4 Uchiha Madara with the Eternal Mangekyou Sharingan, Rinnegan, Mystic Eyes of Death Perception, and Geass doujutsus, equipped with Shining Trapezohedron while casting Super Tengen Toppa Gurren Lagann as his Susanoo, controlling the Gold Experience Requiem stand, having become the original vampire after Alucard, able to tap into the speedforce, wearing the Kamen Rider Black RX suit and Gedou Mazou, with Hashirama Senju's DNA implanted in him so he has mokuton kekkei genkai and can perform yin yang release ninjutsu while being an expert in kenjutsu and taijutsu and having eaten Popeye's spinach. I'm talking about sagemode sage of the six paths Juubi Jinchuuriki Gedou Rinne Tensei Legendary Super Saiyan 4 Uchiha Madara with the Eternal Mangekyou Sharingan, Rinnegan, Mystic Eyes of Death Perception, and Geass doujutsus, equipped with his Shining Trapezohedron while casting Super Tengen Toppa Gurren Lagann as his Susanoo, controlling the Gold Experience Requiem stand, having become the original vampire after having absorbed Alucard as well as a God Hand, able to tap into the speedforce, wearing the Kamen Rider Black RX suit, with Kryptonian DNA implanted in him and having eaten Popeye's spinach while possessing quantum powers like Dr. Manhattan and having mastered Hokuto Shinken.
Sperm is just a fertilizer with half of DNA, people were NEVER a sperm, retard Also the fastest sperm doesn't fertilize the egg, the egg chooses the sperm
And sperm is just a fertilizer with half of DNA, you were never a sperm
Sperm is just a fertilizer with half of DNA, you were never a sperm. Also too late...sperm is produced constantly and dies after few days but a woman is born with all her eggs...should've been swinging intel and cisco instead of chilled in your mom's ovaries as an unfertilized EGG cell I wonder why people ALWAYS try to pretend we started as a sperm and not the egg when it's quite the opposite
Travel Time to Mars = NINE MONTHS Chance of safe landing on Mars with next to ZERO air resistance and large payload = 1 IN 1,000,000 Next launch window back to Earth = TWO YEARS Travel Time to Earth from Mars = TWO YEARS (using basic minimal delta-v launcher) Accumulative deadly radiation = 400 days (Human DNA would 'unstitch' at this point) Speed of DEADLY cosmic radiation 400km/s THIS IS THE REASON WHY. ...and lest we not forget the food and water requirements... 700-900 g per person per day 2,500-3,200 calories per day 1.5+ tonnes of dry food per person 11+ tonnes of water per person Any takers? Thought not... 4.75 YEARS with no internet Oh WAIT, there is more! Bone demineralisation begins within **days**. Measurable bone loss occurs within **weeks**. Clinically significant loss occurs within **months**. For a multi-year Mars mission without artificial gravity, bone health becomes one of the primary life-support problems alongside radiation, food, water, and psychological health.
May be different from the outside, but from the inside they likely share lots of the same lingering DNA
🍿 Between Iger and Jobs is a very long history starting with the threat of home video early 2000s. We called it "second session" and "side loading". In the end, Jobs admired Disney for branding. Iger admired Apple for innovation. The Pixar purchase was supposed to be the DNA/cross pollination panacea, but just say from direct experience, the 2 groups had so much friction the marriage was over before Job's passing. Fast forward after Disney bought all those other companies, the threat was...Amazon. Apple would have been a solution, but luckily Amazon never got traction e.g. MGM until recent (and compared to Netflix) and hence Iger dropped the topic, covid hit, and the rest is history.
The Korean market has convinced me Koreans have YOLO gambling built into their DNA
ADTX- new funding is driving the stock up **Core Focus**: Improving immune health through technologies like: * **AditxtScore** and **FlowSpot**: Tools for monitoring immune profiles (e.g., detecting attacks on or by the immune system). * **Apoptotic DNA Immunotherapy (ADI)**: A nucleic acid-based approach (e.g., **ADI-100**) mimicking natural tolerance induction, aimed at applications like skin grafting, psoriasis, and Type 1 diabetes. * Ignite Proteomics SPAC Deal (major driver): In early June 2026, Aditxt signed a definitive agreement to spin off its subsidiary Ignite Proteomics via a business combination with Copley Acquisition Corp (SPAC). This values Ignite at \~$150 million (implied equity at $10/share reference price for the new Pubco, targeting NYSE listing). Aditxt would retain a stake while becoming a separate Nasdaq entity. This unlocks value from the oncology diagnostics asset and has driven surges (e.g., 40-90%+ moves, with new 10%+ holders emerging)
🎶 This is more than just a game it's our DNA 🎵
not "everyone else can", at all. If you're gonna be a Big Boy in the cloud/compute space, you'd best have serious ability to sell to corporates/gov/military/intelligence . I'm don't think Meta has any DNA in that area; it'd take an acquisition, and that kind of upside would be priced in. Famously, even Apple thoroughly failed to significant in this space.
Yea but the cumulative DNA of like 18 babies in 9 months is larger than one daughter?
(Assuming you're a dude) Since the X chromosome is three times bigger than the Y chromosome a daughter actually has more of the father's DNA than a son.
It is incredibly important that you get a DNA test to prove that you are the father of your child. Otherwise you're going to be wasting a lot of time, money, and energy on a kid that doesn't belong to you.
By culture and DNA you mean swastikas and child porn?
Saw a segment on FoxBusiness the other day about founder-lead companies are leading the gains currently. But then you’ve got Apple without Steve Jobs. After he left in 1985, Apple went to crap; he came back and revitalized it and made sure it would continue to do so. I guess it fully depends on how much Elon puts into the culture and DNA of his companies that they continue to perform without him.
Preferably two to make sure the DNA is passed on.
We don’t even know how to keep people shielded from radiation in open space, and mars doesn’t have an atmosphere. Those colonists’ DNA would be getting sliced into confetti by cosmic rays lol
Elon never lost his mind. He had great PR and then fired them because he felt like PR didnt matter anymore. He is a silver spoon son of an apartheid emerald mine investor. His maternal grandparents moved from Canada to South Africa because they liked apartheid. His dad groomed and impregnated his drag addict step daughter. This is the environment He comes from. The guys pushing great replacement stuff and and having a chatbot that undresses minors has this all in his DNA. He didnt lose his mind.
Allright folks, I know a lot of you are getting jittery and nervous given how much this keeps dragging out. I just want to remind everyone that what Chardan appear to be doing here is borderline some of the greatest financial engineering you will ever see - they are spinning so many plates and everything must be de-risked to the Nth degree in order to execute this properly. As we all know, we've had a few recent developments: \- SONM received NASDAQ delisting notice on 22nd May \- SONM cancelled the ChEF \- SONM announced a pivot into decentralised AI \- Qumulus filed an unexpected 6th amendment to their S1 So what the hell is going on? Let's start with Qumulus and the direct listing. Some highlights from their most recent S1-A: \- ATW facility doubled to $90 million \- New co-location facility in Denver, Colorado \- $124 million in secured contracts \- Q1 financial statements prepared Now I can already hear the wheels spinning in your head: if they have secured contract pre-payments and a $90 million facility, do they really need a public vehicle? Can't they just proceed with direct listing? Theoretically the answer is yes - IF everyone involved in this transaction hates money. Yes they have the $90 million and some prepayments, but this is a drop in the water when compared vs their 2026 business plan of 23k B300s, which would require roughly $1 billion. It's worth noting that the [USD.AI](http://USD.AI) facility they signed up to last October has now been completed tapped. Because they have had zero cash the last 8 months, they've not been able to find the 30% they needed for the deposit, and they've only been able to use $20 million of the facility and everyone else has jumped in front of them and signed $550 million in term sheets even though [usd.ai](http://usd.ai) only has $350 million or so in deposits. So Qumulus are even more fucked than they were 3 months ago because the entire facility is gone until [usd.ai](http://usd.ai) find more depositors. Meaning they need a reverse merger vehicle more than ever. The $90 million from ATW & pre-payments gives them enough to buy roughly another 2k GPUs - a drop in the ocean. Other reasons they won't direct list: Firstly, if they were to proceed with the direct listing, it would mean the company cannot raise money via capital markets for 1 year. A one year delay in raising capital = 1 year delay in execution, meaning 1 year's worth of lost contracts, which could be in the billions. It ain't happening. Secondly, direct listing means anyone with more than 10% is locked in and cannot sell. Guess who has more than 10% of the company? The two founders. If a direct listing happened, the two founders would be left holding the bag. Don't believe me? Look at the last 18 direct listings since end of 2024. The majority of those companies are either 80% down, trading under $1 or have delisted. Direct listings are liquidity events. Qumulus need capital. Thirdly, ATW are Chardan's sister company - they share a co-founder. They are financially motivated to maximise Qumulus' share price. Fourthly, the legal opinion of Fox Rothschild - Qumulus' lawyers - remains absent. It is the only missing exhibit from the most recent S1-A. If Qumulus was genuinely going for a direct listing, why leave out the legal opinion to be filed later down the line, which would mean another round of SEC review and further delay? Take a look at any other direct listing on edgar from the last 18 months - the legal opinion either appears in the original S1 or within 1 or 2 amendments. We are six amendments in and the legal opinion is missing. Why? Because the legal opinion will be different for a reverse merger. Let's move on to SONM. Hindsight is beautiful thing. Admittedly I have not predicted everything perfectly and I don't have a crystal ball. But what I have realised with every filing/event is that things make more and more sense with the benefit of hindsight. I strongly believe the NASDAQ delisting warning was manufactured as a catalyst by Chardan (not that it needed much manufacturing). By manufacturing, I mean delaying the transaction long enough such that an external event - nasdaq's delisting threat - necessitated the transaction. This event provides SONM with the perfect cover to complete the transaction without the accusation that the merger was pre-planned. No SEC lawyer will ever successfully argue that a publicly listed company manufactured its own delisting threat - it would sound utterly ridiculous to any judge. Something similar happened with Movano/Corvex: within 1 week of the NASDAQ delisting warning, they signed an LOI to explore a reverse merger, which completed a few weeks later. The ChEF cancellation was expected - you cannot sign a merger deal while an offering of shares is valid that the merger counter-party has no veto on. This is exactly what happened again in the case of Corvex/Movano. Their S1 says: "We will not sell any Purchase Shares to Chardan without the prior written consent of Corvex (as defined below) prior to the closing of the Merger" Additionally, Chardan cannot have an active ChEF with SONM while advising Qumulus on the merger because there would be a conflict of interest. This was also the case again with Corvex/Movano: "the draft term sheet delivered on June 7, 2025 reflected the parties’ understanding that Chardan had been acting as advisor to each of Rorschach and Sonnet, and that **Chardan intended to resign from the latter engagement** with respect to the Transactions prior to execution of the term sheet. The draft term sheet also anticipated that Sonnet would **reengage Chardan as its advisor with respect to any financing in support of the Transactions**," So the ChEF cancellation had to happen, and it will re-appear in the merger S1 prospectus once the 8k is filed. Now let's talk timelines. We have a hard deadline of 26th September because this is the "public listing date" set out in the ATW convertible note. If Qumulus is not public by then, ATW liquidates Qumulus. They have a gun to their head. And that gun is the direct listing itself - remember what I said about the founders? Now, realistically there is an even sooner deadline: mid-August. There are three converging events pointing to this date: 1) SONM AGM - must be within 13 months of last AGM, which was 18 July last year 2) SONM Q2 results - due 15th August, another quarter of no revenue = death sentence 3) Qumulus Q1 statements - these go stale on 13th August All this means that a shareholder vote must be held by 13th August at the latest. Working backwards, shareholders must have at least 20 days' warning of the vote, and the SEC must have at least 10 days to review the proxy. This puts us at an announcement by Monday 13th July at the absolute latest. However, it leaves no headroom if the SEC has further comments on the prospectus (theoretically it should not if the S1 has been completely derisked & fully reviewed via the direct listing process). It also does not account for the fact that the NASDAQ hearing must likely happen before then. About the NASDAQ hearing panel. If the plan SONM are presenting to Nasdaq is a transformative merger, they need to have 'pro forma' financials that are not stale. Pro forma = as if. In other words, what the financials of the combined company would look like. So in this sense, the Q1 financials we saw this week in the most recent Qumulus S1-A were mandatory, and they are doing well to again get these reviewed by the SEC before the panel happens. All this to say: everything is pointing towards an announcement around end of June/beginning of July. This also coincides with 3 other things we know: 1) The now defunct put option, which had an expiry date of 30 June 2) The QumulusAI roadmap - according to their own tweets, GPU deployment ramps to 9k GPUs in Q3 3) The IXP deployment plan - which begins [by July ](https://www.qumulusai.com/articles/moonshot-and-qumulusai-announce-strategic-agreement-with-connected-nation-internet-exchange-points-to-deploy-a-nationally-distributed-ai-compute-and-internet-exchange-platform)latest according to their own press release I'm not going to sit and pretend like I haven't given 5 or 6 wrong predictions on dates before. But in hindsight, it's easy to see why I was wrong. Someone mentioned earlier in the comments that this path was supposed to be faster and if anything it has been slower. And yes, I was wrong to think they went about it this way because it would be faster. They went about it this way because it was the only way they could do it, and that has meant waiting and putting on a show for the regulators. I should say here that Chardan do not appear to be doing anything illegal by engineering things this way. They just appear to be bending the rules of what is allowed. One final note. I too have wondered if there are other public vehicles that they could pivot to and my search yielded nothing. I screened over 4,000 NASDAQ companies with the following criteria: 1) Under $100 million market cap 2) Trading over $1 dollar 3) US-based (important if they want to chase government contracts, which they do) 4) Under 5 million outstanding shares This screening yielded some 63 companies out of the 4,000+ listed. I then looked at all 63 companies more closely - press releases, filings, financial advisors, the works. None of the companies presented links as strong as SONM, and the few possible candidates (roughly 5) either had issues with their corporate governance, share structure or just bad finances. It's SONM or bust for Qumulus. And bust would be a direct listing. Let's see if everyone involved here - Chardan, Qumulus, SONM, DNA & ATW - hates money. I'm betting on everyone's self interest.
Technically, it's called a DNA Packet.
Key Ingredients Banned in Europe but Allowed in the U.S. Got to give credit to Europe, atleast they ban some of the chemicals they allow here Titanium Dioxide (E171): A whitening agent commonly used in candy, salad dressings, and coffee creamers. It was banned in the EU due to concerns over its ability to accumulate in the body and potentially cause DNA damage. Potassium Bromate (E924): A dough strengthener and whitener used to make industrial bread and baked goods. Banned in the EU, Canada, and Brazil due to links to cancer and kidney issues.BHA and BHT: Common chemical preservatives used in mass-produced cereals, cake mixes, and corn chips to extend shelf life. Both are severely restricted in the EU. Propylparaben (E217): An antimicrobial preservative used to lengthen the shelf life of packaged baked goods and tortillas. It was banned in the EU due to potential endocrine disruption and reproductive toxicity. Ractopamine: A growth-promoting drug given to farm animals in the U.S. to increase leanness. It is banned in over 160 countries, including all of Europe and China, due to health concerns in both humans and animals.
If I keep options running on this account the only thing I'm really interested in is buying LEAPs on longshots I really like. CRSP, DNA, ACHR, RIVN and a couple others. Farming some premiums with the theta gang is also very tempting.
He was a financial executive of ginkgo bioworks $DNA -98% stock price, and a financial executive of Astra $ASTR (now delisted to avoid bankruptcy) which was also similarily -99% or so. So his last two companies he worked at in an executive financial role basically lost the entire value of the company
DNA is only 16.61 kb? If so then when will reddit offer us fanboys an IPO that we can profit from. Or should we Gamestonk pump and dump elons pet funding project.
The mental illness in this thread is palpable. It's like you think life IA an anime or something. 0s in your bank account does not change your DNA ya psychos.
It’s a long way from being on par because of cost. If it were cheaper there would never be a reason to use short reads. So if you think PacBio will take market share it mostly comes down to the Revio 2 outperforming the next Illumina instrument on cost, which is possible but highly unlikely based on past improvement rates and the fact that Illumina can drop consumable costs until PacBio goes bankrupt if it has to. Comparing BioNano is entirely fair as an example of a company in the biotech instruments space that investors had high hopes in, with a proven and unique technology related to genomics, that essentially failed without getting bought up. It’s irrelevant to my point that it’s not DNA sequencing. It’s more likely that long reads won’t take market share at this point. Look at the revenue trends in the past 5 years. Also consider how sequencing is being used increasingly for single cell RNA-seq which is almost fully dominated by Illumina because long reads give almost no advantage there. I work in this field and I’m invested in PacBio and ONT so I’m not talking out of my ass. At the moment I think it’s hard to deny that the future is not bright for long reads, even if they stay around as a niche product for genome assembly.
New York Time Scientists have edited the DNA of early human embryos with unprecedented accuracy, an achievement that could open the way to babies engineered with particular characteristics. TLDR: Alcoholism, propensity for gambling, and regard genes are being edited out for the next generation. Calls.
What do you mean a long way away from being on par with short reads? It’s already better in some regards, the main limitation really being cost which is being actively reduced and also throughput perhaps. Comparing BioNano to long read sequencing is not a fair comparison. BioNano’s tech operates in a tiny niche of a niche, it’s not even classified as DNA sequencing and isn’t comparable to dna sequencing companies really. Obviously PacBio isn’t going to overtake Illumina any time soon or perhaps ever. It doesn’t mean PacBio can’t grow significantly. Long reads sequencing will continue take market share as costs reduce because there are limitations that short will never overcome.
Porsche is a German automotive manufacturer renowned for producing high-performance sports cars, SUVs, and sedans. The brand is synonymous with a unique blend of racing heritage, engineering excellence, and everyday usability. History and Foundation The company's story begins with its founder, Ferdinand Porsche, a brilliant engineer who had a significant impact on the automotive world. Before founding his own company, he worked for other prominent manufacturers, including Daimler. One of his most famous early projects was designing the Volkswagen Beetle for the German government. In 1931, Ferdinand Porsche established "Dr. Ing. h.c. F. Porsche GmbH" in Stuttgart, Germany. Initially, the company focused on design and consulting work, but it was his son, Ferdinand "Ferry" Porsche, who would build the first car to bear the Porsche name. * The Porsche 356 (1948): This was the first official Porsche sports car. It was lightweight, agile, and featured an air-cooled, rear-engine design, which became a signature for the brand. The 356 laid the groundwork for Porsche's future success in the sports car market. * The Porsche 911 (1964): Designed by Ferdinand "Butzi" Porsche, Ferdinand's grandson, the 911 is arguably the most iconic and recognizable sports car ever made. With its distinctive design and rear-engine layout, the 911 has been in continuous production for decades, evolving through numerous generations while maintaining its core identity. Key Models and Innovations While the 911 remains the brand's flagship, Porsche has expanded its lineup over the years to include a diverse range of vehicles, each carrying the brand's DNA of performance and precision. * 911 Turbo: A high-performance variant of the 911, known for its incredible speed and turbocharged power. * Boxster and Cayman: Mid-engined sports cars that offer exceptional handling and balance. The Boxster is a roadster, while the Cayman is a coupe. * Transaxle Cars (924, 944, 928): In the 1970s and 80s, Porsche introduced front-engine, rear-transaxle models like the 944 and 928, which were praised for their balanced handling and offered a different driving experience. * Cayenne and Macan: The Cayenne, a luxury SUV introduced in 2002, was a significant departure for the brand but became one of its best-selling models, establishing the high-performance SUV as a legitimate segment. The Macan is a smaller, compact luxury SUV. * Panamera: A four-door luxury sedan that brings sports car performance to a more practical format. * Taycan: Porsche's first all-electric sports car, the Taycan demonstrates the brand's commitment to innovation and high-performance electric vehicles. Racing Heritage Porsche's identity is deeply intertwined with motorsports. The brand has a legendary history in racing, with an estimated 24,000 race wins around the world. Porsche has achieved remarkable success at the 24 Hours of Le Mans, the most prestigious endurance race in the world, with over 50 class wins and a record number of overall victories. The 917 race car, which won Le Mans in 1970 and 1971, is one of the most legendary race cars in history. This racing DNA is a core component of every Porsche, influencing the design and engineering of its road cars. #foryoupage❤️❤️ #foryou #for
>2023–2026: “AI will change the world.” >2027–2035: “Have you updated your DNA yet?” Wait next year they're just gonna jump to gene editing before AI delivers on all these promises? Will they then just jump to something new in 2036 before I get my gene editing?
I don't believe that is accurate. Might want to wait until after the mid-June Falcon 9 launch 🚀 or research the myriad of other hand Rocket companies bit more. I pondered shorting ASST but after receiving some valuable intel, Im considering Calls. I possibly know someone on the inside that I may have shared DNA with (allegedly of course) explain to me last night the current situation going forward. ASTS SpaceMobile is preparing it's mid-June SpaceX Falcon 9 launch, with BlueBirds payload satellites 8, 9, and 10. The status of the satellites is as follows: BlueBirds 8 and 10 have officially arrived at Cape Canaveral, FL. BlueBird 9 has been dispatched from the Texas production facility and is en route to Florida to join the 8 & 9 for payload processing. Launch provider: SpaceX Falcon 9 Timeline: Scheduled mid-June at Cape Canaveral, FL *(Following the standard 3-to-4 week integration window with SpaceX)
his DNA was infused with a trading algo code
DNA is a biotech platform for AI
I just looked that up… and wow. I hate to looks shame anyone… but, I would not be surprised to see draconian-human hybrid DNA in that 23 and me.
Mine is CRSP. I keep it mainly because it is a huge scientific history and I want to be a part of it. It is a sequence of DNA that allows for gene editing. And I believe that, using this technology, some amazing medical breakthrough will be achieved.
Maybe if you combine their DNA it will create a child that buys low and sells high
DNA storage systems, using dna to store information
There's no decision to delist them. NASDAQ issues these "decisions" every day but gives companies the opportunity to present a "plan". The 8-k clearly says SONM intend to request a hearing and present a plan. The plan doesn't have to be actioned. They just have to show that they've got a plan. The NASDAQ doesn't want to delist companies and destroy shareholder value willy-nilly. All that said, I DO believe the merger will close before the hearing. That in itself is the plan. And the convertible note from DNA holdings is enough in any case to bridge the gap if the merger needs more time. As is the ChEF if they need it. They've got options. Qumulus won't give a fuck about this delisting notice. The nasdaq is not going to delist a $2 billion dollar company.
23andMe is flawed It will not test for ancient Hebrew DNA
Tons of those Spacs boomed eventually. I held a few and the roller coaster was wild. Everyone tried to crush my soul. Wins: rklb, pl, draftkings and total loses like DNA.
Im a Network Solutions Architect and I’ve focused on Juniper solutions for almost 20 years. Their MIST platform is really good for enterprise networks. APSTRA for Data Centers is also good. Price increases and supply chain constraints starting last year have caused orders to be delayed. Currently there is a 200ish day lead time on switching hardware for example. This has caused a lot of deals that were in flight which would normally have closed in Q4 to slip until Q1. Cisco has required DNA license pricing even if you don’t use the features which is really frustrating a lot of customers and they are pricing themselves out of a lot of business right now. Juniper (now HPE) has been taking market share from Cisco with their new cloud based AI solutions and aggressiveness on price.
You cannot convince me he doesn’t have 25+% Neanderthal DNA
How did multiple donor semen from different DNA donors get into his mom?
Yeah it won’t work. Facebook is about social circles, your neighbours, your family, etc. Forums will end up being locally significant due to this, garage sales, local swaps/meetups, block parties/groups and of course nosy neighbourhood watch coordination. People on Reddit organize around topics not locality/social circles. Meta has been trying to do the everything app and in my opinion failing primarily due to not understanding their own ecosystem and user population. It screams desperation. Meta ima give you one for free: buy that failing DNA test company and connect people to lost/distant family members. Create groups for families to organize then layer in financial and social services. Example; Let families donate to a group fund. People on your platform are desperate to virtu single, so let them. Give them a gold star for being a ‘good family member’ when they donate to the group funds. Creating inter and intra family group engagement. Everyone on instagram is either a ‘event organizer’ or ‘entrepreneur’ so put them to work. Group funds from families looking for social interaction in a decaying society can be used by vapid ‘get the bag’ grifters who pretend to do social work. Take your 10% and sit on buckets of cash. Your users too poor? Offer debt! Micro loans, ‘family payment’ plans, and buy now pay later schemes so everyone can suffer together! Wedge yourself further between natural human interaction and extract ‘share holder value’. People will suffer but your stock price will grow!
It speaks to acting on facts rather than emotion. Do I want people to die? No. Am I realistic in the fact that war is part of human nature since the beginning of time? Yes. War is inevitable and in our DNA. I'm realistic.